Skip to main content

Ovart

Assembly of an artificial ovary combining isolated human ovarian follicles, fibrin and a textile pocket The objective of this project is to develop a 3D biodegradable matrix to graft an autologous ovarian tissue or isolated follicles in patients with impaired fertility following a gonadotoxic treatment. This biofunctional fibrin-based matrix will...
Read More

SMART

Statistical Monitoring Applied to Research Trials While the detection of deliberate (fraud) or unintentional errors concern pharmaceutical and biotechnology companies enormously, there is currently no integrated and automated system to monitor the quality of data based on statistical tests and artificial intelligence or data mining. IDDI is a pioneer in...
Read More

StarfloPlus

Glaucoma Management Implant System Research on a next generation Glaucoma Management Implant System that incorporates the latest advances in biomaterials, MEMS sensor and electronics technologies. The goal of the implant system is to provide a novel combination of therapeutic and diagnostic benefits for glaucoma patients and caregivers, while significantly reducing...
Read More

StemVac

Innovative immunotherapy approaches to treat breast cancer patients Breast cancer is the most common malignancy in women and is the second leading cause of cancer deaths (after lung cancer). There is a clear medical need for more efficient breast cancer treatments in terms of distant recurrence and safety and tolerance....
Read More

NeuroAtt

Development of a neuronal technology to detect and treat attention deficit hyperactivity disorder (ADHD) NeuroAtt aims to design novel electrophysiological diagnostic tools (EDT) and brain wave trainers (BWT) in attention deficit hyperactivity disorder (ADHD). It includes the development of methods to analyse multi-channel EEG recordings during sensorimotor and cognitive tasks...
Read More

BENEFIT

The treatment of patients in clinical practice relies on the results of randomized clinical trials. The statistical methods currently used to test the treatment effects in such trials take into account a single criterion called "primary endpoint". This is an incomplete assessment of trial results, especially in oncology and chronic...
Read More